Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Stopped early · Phase 3
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The primary objective of this study is to evaluate the effect of the addition of idelalisib to ofatumumab on progression-free survival (PFS) in participants with previously treated chronic lymphocytic leukemia (CLL).
Key facts
- Study ID
- NCT01659021
- Run by
- Gilead Sciences
- People needed
- 261
- Starts
- 2012-12-04
- Expected to finish
- 2018-08-15
- Last updated by the study team
- 2019-08-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- California Cancer Associates for Research and Excellence (CCARE) — Fresno, California, United States
- Kaiser Permanente — San Diego, California, United States
- Coastal Integrative Cancer Care — San Luis Obispo, California, United States
- Stanford University Medical Center — Stanford, California, United States
- Kaiser Permanente Vallejo Medical Center — Vallejo, California, United States
- Kaiser Permanente of Colorado — Denver, Colorado, United States
- Saint Mary's Regional Cancer Center — Grand Junction, Colorado, United States
- Cancer Specialists of North Florida — Jacksonville, Florida, United States
- Georgia Regents University — Augusta, Georgia, United States
- Montgomery Cancer Center — Mount Sterling, Kentucky, United States
- Center for Cancer and Blood Disorders, PC — Bethesda, Maryland, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Washington University Medical Center — St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Weill Cornell Medical Center — New York, New York, United States
- Oncology Hematology Care, Inc. — Cincinnati, Ohio, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Upstate Oncology Associates — Greenville, South Carolina, United States
- Tennessee Oncology, PLLC — Chattanooga, Tennessee, United States
- Tenessee Oncology, PLLC — Nashville, Tennessee, United States
- Utah Cancer Specialists — Salt Lake City, Utah, United States
- Northwest Medical Specialties — Tacoma, Washington, United States
- Saint George and Sutherland Hospitals — Kogarah, New South Wales, Australia
- City of Hope — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.